News
A clause in Wayne DeVeydt’s new contract prevents him from participating in activities that compete with UnitedHealth. That’s ...
Despite sector-wide cost pressures, UNH outperforms peers in cost management and margins, making recent pessimism appear ...
UnitedHealth stock plummeted 17.46% after my Buy call after missing Q2 EPS expectations by 9%. I see an overreaction creating ...
DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...
Now, DeVeydt—also former chairman and CEO of Surgery Partners and former CFO at Anthem (now Elevance)—will need to play a ...
On Tuesday, UnitedHealth said it expects adjusted earnings of at least $16 a share in 2025. That compares with consensus ...
While use of artificial intelligence in health insurance remains controversial, UnitedHealth Group is full speed ahead on AI.
While UnitedHealth remained profitable, its operating earnings for the three months fell sharply to $5.2 billion from $7.9 ...
Bernstein SocGen Group lowered its price target on UnitedHealth Group (NYSE: UNH) to $337.00 from $377.00 on Monday, while maintaining an Outperform rating on the healthcare giant. The stock, ...
UnitedHealth Group has appointed Wayne S. DeVeydt as its chief financial officer, effective Sept. 2. DeVeydt, 55, replaces John F. Rex, who has been CFO since 2016. Rex will become strategic advisor ...
The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...
UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results